Introduction
============

An estimated 3 billion people cook and heat their homes using biomass fuel obtained from animal or plant materials, such as wood, charcoal, dung, or crop residue.[@R1] Worldwide, 4.3 million people are thought to die prematurely each year from illnesses attributable to biomass smoke exposure.[@R2] Of these deaths, 12% are from to pneumonia, 34% from stroke, 26% from ischaemic heart disease, 22% from chronic obstructive pulmonary disease, and 6% from lung cancer.[@R2] Upper gastrointestinal (UGI) cancers, particularly of the oesophagus and stomach, are yet to be listed among these diseases, but there is emerging evidence that exposure to biomass smoke may be contributing to the pathogenesis of these cancers. In this review, we look at available literature on the influence of biomass smoke exposure on oesophageal and gastric cancer.

Upper gastrointestinal cancer epidemiology
------------------------------------------

It has been estimated that global cancer incidence will nearly double by 2030, and that much of this increase will occur in low- and middle-income countries. Seven cancers account for 70% of the global cancer burden, and oesophageal cancer is the sixth most common cause of cancer death worldwide.[@R3] Most of the cases of oesophageal cancer occur in less developed countries, and it generally affects men more than women. The highest incidence rates for oesophageal cancer are in eastern Asia, at 17 per 100,000 per year in men, closely followed by southern Africa, with about 14 cases per 100,000 per year.[@R3] Oesophageal cancer has a very poor survival, with the highest mortality rates being those for eastern Asia and southern Africa. Accurate data on oesophageal cancer from many African countries remain scanty, mainly due to a paucity of population-based registries in this region.[@R4] Estimates for Africa rank oesophageal cancer as the fifth most common cancer among men and the ninth among women. In southern Africa, it is ranked third among men and fifth among women.[@R5] The American Cancer Society reported the annual incidence rate for the whole of Africa to be 6.7 per 100,000 in men and 3.5 per 100,000 in women (with the highest incidence in southern Africa, at 22.3 per 100,000 for men and 11.7 per 100,000 for women).[@R6] Particularly high rates have been reported in Kenya, Malawi, and the Eastern Cape province of South Africa.[@R3]

Gastric cancer is the fifth most common cancer globally and is third among the causes of cancer mortality. More than 70% of the cases of gastric cancer occur in developing countries, and like oesophageal cancer, it is more common in men than women.[@R3] The highest age-standardised annual incidence rates are from eastern Asia, at 35.4 per 100,000 for men and 13.8 per 100,000 for women. The highest mortality rates are also from eastern Asia, with an estimated 24 and 9.8 per 100,000 for men and women, respectively. North America has the lowest mortality rates, at 2.8 and 1.5 per 100,000 for men and women, respectively.[@R3] Similar to oesophageal cancer, data on gastric cancer from Africa are scarce. GLOBOCAN estimates suggest that the annual incidence of gastric cancer in Africa is 3.3 to 15.4 per 100,000 for men and 2.6 to 8.2 per 100,000 for women. On the other hand, the American Cancer Society report on Cancer in Africa estimates that the annual incidence for southern Africa is 4.1 per 100,000 for men and 2.2 per 100,000 for women, making it the seventh most common cancer among men and eighth among women, respectively.[@R6] In Africa overall, the incidence of gastric cancer is estimated to be lowest in West Africa, while high incidence clusters have been reported around the Great Lakes region, particularly western Uganda, and some parts of South Africa and Mali.[@R5],[@R7],[@R8]

Domestic use of biomass fuel
----------------------------

Humans have traditionally used biomass fuel, as it is inexpensive and readily available. Countries with lower gross domestic product per capita rely more on biomass fuel than the richer countries.[@R9] In Europe, for example, the use has declined to 7%, compared to Africa, where up to 77% of the population still relies on these traditional fuels. A cross-sectional analysis of biomass fuel use in a Malawian peri-urban area showed that only 3.9% of the households were exclusively using electricity for their cooking. Most of the households were using either charcoal or firewood.[@R10] Similarly, in Zambia, 73% and 98% of urban and rural communities, respectively, rely on either charcoal or firewood as fuels.[@R11] Surprisingly, despite the ongoing rural electrification programme in Zambia, the use of charcoal increased from 25% in 2007 to 37% in 2013--2014.[@R11]

Biomass smoke and its similarities to cigarette smoke
-----------------------------------------------------

There is emerging evidence that long-term exposure to biomass smoke exacerbates, and in some cases causes, disease in humans. The International Agency for Research on Cancer (IARC) classified biomass smoke as a probable carcinogen (group 2A)[@R12] because of the growing evidence of its association with certain cancers and a better understanding of its constituents. Cigarette smoke, containing known carcinogens, is associated with several types of cancer, including those of the upper gastrointestinal tract.[@R13] Substances contained in cigarette smoke have been well described, but the content of biomass smoke is more variable and largely depends on the type of biomass being burnt and the temperatures being used.[@R14],[@R15] Incomplete combustion of biomass fuel produces several organic and inorganic compounds, the biological effects of which are not fully understood. [Table 1](#T1){ref-type="table"} lists carcinogenic substances present in both biomass and cigarette smoke.[@R13],[@R16] Among these substances are polycyclic aromatic hydrocarbons (PAH). PAH have been linked to gastrointestinal carcinogenesis.[@R17],[@R18] They are primarily produced from the incomplete combustion of organic matter. They can be metabolised to electrophilic forms that adduct to DNA, resulting in misreplication if not repaired. Exposure to wood smoke particulate matter has beeen found to generate more DNA damage than traffic-generated particulate matter, and it is suggested that this observation may result from the high levels of PAH in wood smoke.[@R19] Clinical studies have shown that long-term exposure to biomass smoke predisposes to DNA damage and oxidative stress,[@R20],[@R21] potential mechanisms of carcinogenesis. In addition, exposure to biomass smoke has been associated with high urinary mutagen content.[@R22]

###### 

Carcinogenic substances present in both cigarette and biomass smoke[@R13],[@R16]

  Group                         Substance             IARC Group   Year of classifcation
  ----------------------------- --------------------- ------------ -----------------------
  **Polycyclic hydrocarbons**   Benz\[a\]anthracene   2A           1987
  Benzo\[a\]pyrene              1                     2012         
                                                                   
  **Aldehydes**                 Formaldehyde          1            2012
  Acetaldehyde                  2B                    1999         
                                                                   
  **Aromatics**                 Benzene               1            2012
  **Inorganic toxins**          Arsenic               1            2012
  Beryllium                     1                     2012         
  Nickel                        2B                    2012         
  Cobalt                        2B                    1991         
  Lead (inorganic)              2B                    1987         

IARC = International Agency for Research on Cancer

Methods
=======

Source of information
---------------------

A literature search was conducted using the electronic database PubMed. We used the search queries "biomass smoke", "wood smoke", "charcoal smoke", "oesophageal cancer", "gastric cancer", and "Africa", each on their own and in combinations, with the timeframe specified to between January 1980 and February 2016, inclusive. Using these key words, we read through 806 titles and abstracts, and 55 original articles were then chosen, as they referred to cancer and biomass smoke. Sixteen articles that did not address the association between biomass smoke exposure or its metabolites on various cancers were excluded, and 39 full articles were then selected based on the specific relevance of their content to the intended subject matter of this review ([Figure 1](#F1){ref-type="fig"}). Articles that presented negative findings were also reviewed.

![Flow chart showing the selection of articles from PubMed](MMJ2902-0212Fig1){#F1}

Results
=======

Using our search terms, we identified 10 studies that reported an effect of exposure to biomass smoke on UGI cancer ([Table 2](#T2){ref-type="table"}), all of which reported a significant association. A case-control study of oesophageal cancer patients in Zambia, with age- and sex-matched controls, revealed a significant association with biomass smoke exposure.[@R23] Investigators from South Africa reported similar findings, demonstrating a link between SNPs in miR-423 associated with oesophageal cancer and environmental smoke exposure.[@R24] Earlier results, also from South Africa, showed an association between biomass smoke exposure and gene polymorphisms linked with the development of oesophageal cancer.[@R25] In 2006, Dandara et al. reported a significant association between oesophageal cancer and use of biomass fuel.[@R26] In Kenya, at a hospital in which oesophageal cancer was the most common cancer among men, cooking with biomass fuel was found to be a significant risk factor.[@R27] In a low-incidence area of Brazil, exposure to biomass smoke was similarly found to be associated with oesophageal cancer.[@R28] More recently, a case-control study from Malawi also reported a significant association between biomass smoke exposure and oesophageal cancer.[@R29] A large study conducted in Eastern Europe also demonstrated a link between biomass fuel and oesophageal cancer.[@R30]

###### 

Studies that have evaluated the influence of biomass smoke exposure on cancer risk

  ------------------------------------ -------------- ------------------------- ----------------- -------------------------------------------- -----------------------------------------
  **Upper gastrointestinal cancers**                                                                                                           

                                                                                                                                               

  **Study**                            **Study**\     **Cancer**\               **Sample size**   **Odds Ratios (OR), Relative Risk (RR),**\   
                                       **location**   **type**                                    **95% Confidence Intervals (CI),**\          
                                                                                                  **P-values**                                 

                                                                                                                                               

  **Cases**                            **Controls**                                                                                            

                                                                                                                                               

  Kayamba, 2015[@R21]                  Zambia         Oesophageal               50                50                                           OR= 3.6; 95% CI = 1.4 to 9.3; P = 0.004

  Wang, 2013[@R22]                     South Africa   Oesophageal\              565               1003                                         OR= 1.75; 95% CI = 1.24 to 2.46;\
                                                      (gene-environment\                                                                       P = 0.001
                                                      interaction)                                                                             

  Li, 2010[@R23]                       South Africa   Oesophageal\              245               288                                          OR = 12.1; 95% CI = 3.26 to 49
                                                      (gene-environment\                                                                       
                                                      interaction)                                                                             

  Dandara, 2006[@R24]                  South Africa   Oesophageal               63                20                                           OR = 15.2; 95% CI = 8.15 to 28.2;\
                                                                                                                                               P = 0.0001

  Patel, 2013[@R25]                    Kenya          Oesophageal               159               159                                          OR = 2.32; 95% CI = 1.41 to 3.84;\
                                                                                                                                               P \< 0.001

  Mota, 2013[@R26]                     Brazil         Oesophageal               99                223                                          OR = 4.42; 95% CI = 2.35 to 8.32;\
                                                                                                                                               P \< 0.001

  Mlombe, 2015[@R27]                   Malawi         Oesophageal               96                180                                          OR = 12.6; 95% CI = 4.2 to 37.7

  Sapkota, 2013[@R28]                  Multicentre    Oesophageal               1110              186                                          OR = 2.71; 95% CI = 1.21 to 6.10

  Chirinos, 2012[@R31]                 Peru           Gastric                   96                96                                           OR = 5

  Rafkin, 2015[@R32]                   Honduras       Gastric                   814               1049                                         OR = 3.54; 95% CI = 2.18 to 5.77

                                                                                                                                               

  **Other cancer types**                                                                                                                       

                                                                                                                                               

  **Study**                            **Study**\     **Cancer**\               **Sample size**   **Odds Ratios (OR), Relative Risk (RR),**\   
                                       **location**   **Type**                                    **95% Confidence intervals (CI),**\          
                                                                                                  **P-values**                                 

                                                                                                                                               

  **Cases**                            **Controls**                                                                                            

                                                                                                                                               

  Gerhardsson de\                      Sweden         Colon Rectal              21                27                                           RR = 1.2; 95% CI = 0.6 to 2.2\
  Verdier, 1992[@R38]                                                                                                                          RR = 1.9; 95% CI = 1.0 to 3.7

  Raspanti, 2016[@R39]                 Nepal          Lung                      606               606                                          OR = 1.77; 95% CI = 1.00 to 3.14

  Saikia, 2014[@R40]                   India          Lung                      272               544                                          OR = 3.6; 95% CI = 1.85 to 6.98;\
                                                                                                                                               P \< 0.001

  Phukan, 2014[@R41]                   India          Lung                      230               460                                          OR = 1.5; 95% CI = 1.01 to 2.22;\
                                                                                                                                               P = 0.044

  Sloan, 2012[@R42]                    USA            Lung                      277               251                                          OR = 2.43; 95% CI = 1.26 to 4.67\
                                                                                                                                               P = 0.008

  Hernández-Garduño, 2004[@R43]        Mexico         Lung                      113               273                                          OR = 1.9; 95% CI = 1.1 to 3.5

  Levin, 1988[@R44]                    China          Lung                      738               760                                          OR = 1.8; 95% CI = 1.3 to 2.5

  Sierra-Torres,\                      Colombia       Cervical                  91                92                                           OR = 3.3; 95% CI = 0.5 to 22.5
  2006[@R45]                                                                                                                                   

  Velema, 2002[@R46]                   Honduras       Cervical                  45                241                                          P = 0.022

  Ferrera, 2000[@R47]                  Honduras       Cervical                  99                198                                          P = 0.0001

  He, 2015[@R48]                       China          Nasopharyngeal            1845              2275                                         OR = 1.95; 95% CI = 1.65 to 2.31

  Pintos, 1998[@R49]                   Brazil         Oral\                     373\              1568                                         OR = 2.73; 95% CI = 1.8 to 4.2\
                                                      Pharyngeal\               217\                                                           OR = 3.82; 95% CI = 2.0 to 7.4\
                                                      Laryngeal                 194                                                            OR = 2.34; 95% CI = 1.2 to 4.7

  Sapkota, 2008[@R50]                  India          Hypopharyngeal            799               1062                                         OR = 1.62; 95% CI = 1.14 to 2.32

  Greenop, 2015[@R51]                  Australia      Childhood brain tumours   306               950                                          OR = 1.51; 95% CI = 1.05 to 2.15
  ------------------------------------ -------------- ------------------------- ----------------- -------------------------------------------- -----------------------------------------

While this review is focused on upper gastrointestinal cancers in Africa, studies from other geographical locations and reporting about other cancer types are included to illustrated similarities.

Only two relevant studies of gastric cancer, both from outside Africa, were identified. A case-control study done in Peru, involving 96 gastric cancer cases and 96 controls, revealed a significant association between biomass fuel use and gastric cancer.[@R31] Data from a study in western Honduras revealed a significant association between gastric cancer and the use of wood stoves, from which biomass smoke is emitted.[@R32]

Discussion
==========

This review outlines a collection of evidence in support of an association between biomass smoke exposure and UGI cancers. There is an overlap of established oesophageal and gastric cancer risk factors, and it is therefore likely that biomass smoke could be influencing the development of both types of malignancy. In addition, the review has brought out similarities in the carcinogenic content of cigarette and biomass smoke, with the possibility of common disease associations.

Cancer is an increasing health problem in Africa, partly due to ageing and expanding populations, reduced mortality from infectious disease, and (likely) increased exposure to cancer-causing agents.[@R33] In Zambia, for example, a retrospective audit of endoscopic records, covering a period of close to four decades, revealed an increase in UGI cancer diagnosis among individuals below the age of 60 years.[@R34] Interestingly, the frequency of diagnosis among patients over the age of 60 years remained the same over this period. Similarly, there has been an increase in oesophageal cancer in Ghana, where up to 25% of the cases are below the age of 50 years.[@R35] It remains unclear, however, if these are true increases in incidence or just a reflection of improved diagnostic facilities. We therefore saw the need to conduct a literature review with the intension of contributing to the understanding of UGI cancer development in low-resource settings.

Most studies that have linked biomass smoke to oesophageal cancer are from Africa. All show clear associations, but little is understood about the exact pathogenesis. Similar to cigarette smoke, the carcinogens in biomass smoke are inhaled, but could also be swallowed, and the effect on distant tissues suggests systemic spread. UGI cancers are more common in communities of low socioeconomic status, even within the same geographical region.[@R4],[@R36],[@R37] Notable deficiencies in these poor communities include clean water, sanitation, good housing, and electricity. Therefore, there is heavy reliance on biomass fuels and, in turn, exposure to smoke and its hazardous constituents. It has been suggested that communicable diseases could be responsible for the higher incidence of UGI cancers in poor communities, but this explanation is far from complete, as many such cancers are not solely caused by infections. It is therefore more likely that other environmental factors, such as biomass smoke exposure, are influencing the development of UGI cancers in these communities. Two of the studies included in this review are from Zambia and Malawi---neighbouring countries with similar populations and socioeconomic environments. Identification of this common problem clearly demonstrates the need for feasible risk reduction strategies applicable to both countries. Finding alternative affordable fuels that could be used in these countries remains challenging.

In [Table 2](#T2){ref-type="table"} we went further to summarise studies that have linked biomass smoke exposure to other cancer types. This was done in order to emphasise the understanding that cancers at different sites do sometimes use similar pathogenic mechanisms in their development. In addition, the table shows data from which we could postulate that minimising exposure to biomass smoke might contribute towards a reduction of other cancers as well. The lower gastrointestinal tract is not spared, exemplified by a study from Sweden involving more than 500 colorectal cancer patients reported an association with biomass smoke exposure.[@R38]

Lastly, this review has demonstrated the need to design studies that would explore the causative link between biomass smoke exposure and UGI cancers. These future studies could also include direct analysis such as air monitoring, or indirect measures with biomarkers.

Conclusions
===========

In conclusion, we have shown that exposure to biomass smoke is associated with oesophageal and gastric cancer. The similarities of carcinogenic content between cigarette and biomass smoke further supports this theory. If it is correct, then reducing dependence on biomass fuels will have an impact on the occurrence of UGI cancers.
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